These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9199758)

  • 1. Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres.
    Chiba M; Hanes J; Langer R
    Biomaterials; 1997 Jul; 18(13):893-901. PubMed ID: 9199758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery.
    Hanes J; Chiba M; Langer R
    Biomaterials; 1998; 19(1-3):163-72. PubMed ID: 9678864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery.
    Kipper MJ; Shen E; Determan A; Narasimhan B
    Biomaterials; 2002 Nov; 23(22):4405-12. PubMed ID: 12219831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of polyanhydride microspheres for basal insulin delivery: Effect of copolymer composition and zinc salt on encapsulation, in vitro release, stability, in vivo absorption and bioactivity in diabetic rats.
    Manoharan C; Singh J
    J Pharm Sci; 2009 Nov; 98(11):4237-50. PubMed ID: 19472196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release.
    Bittner B; Witt C; Mäder K; Kissel T
    J Control Release; 1999 Aug; 60(2-3):297-309. PubMed ID: 10425335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and in vitro degradation of salicylate-derived poly(anhydride-ester microspheres).
    Yeagy BA; Prudencio A; Schmeltzer RC; Uhrich KE; Cook TJ
    J Microencapsul; 2006 Sep; 23(6):643-53. PubMed ID: 17118880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study.
    Jameela SR; Suma N; Jayakrishnan A
    J Biomater Sci Polym Ed; 1997; 8(6):457-66. PubMed ID: 9151193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine.
    Shelke NB; Aminabhavi TM
    Int J Pharm; 2007 Dec; 345(1-2):51-8. PubMed ID: 17616283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs.
    Fiegel J; Fu J; Hanes J
    J Control Release; 2004 May; 96(3):411-23. PubMed ID: 15120898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled delivery systems for proteins using polyanhydride microspheres.
    Tabata Y; Gutta S; Langer R
    Pharm Res; 1993 Apr; 10(4):487-96. PubMed ID: 8483830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anhydride oligomers within polymer microsphere blends and their impact on bioadhesion and drug delivery in vitro.
    Santos CA; Freedman BD; Ghosn S; Jacob JS; Scarpulla M; Mathiowitz E
    Biomaterials; 2003 Sep; 24(20):3571-83. PubMed ID: 12809786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-catalyzed poly(ortho ester) microspheres: a study of their erosion and drug release mechanism.
    Chia HH; Yang YY; Chung TS; Ng S; Heller J
    J Control Release; 2001 Jul; 75(1-2):11-25. PubMed ID: 11451493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyanhydrides. V. Branched polyanhydrides.
    Maniar M; Xie XD; Domb AJ
    Biomaterials; 1990 Nov; 11(9):690-4. PubMed ID: 2090304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes.
    Jiang HL; Zhu KJ
    Int J Pharm; 2000 Jan; 194(1):51-60. PubMed ID: 10601684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds.
    Tabata Y; Langer R
    Pharm Res; 1993 Mar; 10(3):391-9. PubMed ID: 8464812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release of model compounds with different hydrophilicity from poly(ester-anhydride) microspheres.
    Jaszcz K
    Acta Pol Pharm; 2013; 70(6):1051-63. PubMed ID: 24383329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of additives on the release of a model protein from PLGA microspheres.
    Kang F; Singh J
    AAPS PharmSciTech; 2001 Dec; 2(4):30. PubMed ID: 14727867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incorporation and release of bovine serum albumin from poly(beta-hydroxybutyrate-hydroxyvalerate) microspheres.
    Atkins TW; Peacock SJ
    J Biomater Sci Polym Ed; 1996; 7(12):1065-73. PubMed ID: 8880438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable salicylate-based poly(anhydride-ester) microspheres for controlled insulin delivery.
    Delgado-Rivera R; Rosario-Meléndez R; Yu W; Uhrich KE
    J Biomed Mater Res A; 2014 Aug; 102(8):2736-42. PubMed ID: 24027012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.